All Resources

Read all of the latest breakthroughs, insights, and news from Ginkgo.

BlogApril 10, 2024
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
BlogMarch 18, 2024
Welcome Dr. Mitch Wolfe!
BlogFebruary 27, 2024
Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free Zones
BlogSeptember 21, 2021
The End of the Beginning: Ginkgo Goes Public
BlogJune 9, 2021
600,000 Noses Swabbed!
BlogMay 14, 2021
Taking Ginkgo Public on NYSE:DNA
BlogMarch 18, 2021
Why Ginkgo Cares about Genetic Privacy
BlogDecember 8, 2020
Expanding Ginkgo's Platform for Biosecurity and Pandemic Responsiveness
BlogNovember 16, 2020
Webinar: University Leaders on Testing
BlogOctober 23, 2020
Our New Seaport Test Center: Expanding Access to COVID-19 Diagnostic Testing in Boston
BlogJune 30, 2020
Needle in a Haystack: Looking for Compounds to Treat COVID-19
BlogJune 18, 2020
Concentric by Ginkgo: COVID-19 testing at scale
BlogMay 4, 2020
How to Deploy Millions of COVID-19 Tests Per Day
BlogApril 17, 2020
Teaming Up to Improve Antibody Therapeutics for COVID-19
BlogApril 15, 2020
Supporting COVID-19 mRNA Vaccine Development with Moderna
BlogApril 10, 2020
Project Update: COVID-19 DNA Synthesis
BlogMarch 24, 2020
Scaling Up Whole Genome Sequencing of COVID-19
BlogMarch 22, 2020
Synthetic Biology (and beyond) Community response to COVID-19
BlogMarch 20, 2020
Fighting COVID-19 by Synthesizing DNA
BlogMarch 17, 2020
$25M of Free Platform Access for COVID-19 Projects
BlogJune 26, 2018
Our Work on Biosecurity with IARPA